1. 1. Katsushima H, Fukuhara N, Ichikawa S, et al. Non-biased and complete case registration of lymphoid leukemia and lymphoma for five years: a first representative index of Japan from an epidemiologically stable Miyagi Prefecture. Leuk Lymphoma 58: 80-88, 2017.
2. 2. Tan D, Horning SJ, Hoppe RT, et al. Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood 122: 981-987, 2013.
3. 3. Scorzoni L, de Paula e Silva ACA, Marcos CM, et al. Antifungal therapy: new advances in the understanding and treatment of mycosis. Front Microbiol 08: 1-23, 2017.
4. 4. Jang K-S, Kim YH. Rapid and robust MALDI-TOF MS techniques for microbial identification: a brief overview of their diverse applications. J Microbiol 56: 209-216, 2018.
5. 5. Guo L, Ye L, Zhao Q, Ma Y, Yang J, Luo Y. Comparative study of MALDI-TOF MS and VITEK 2 in bacteria identification. J Thorac Dis 6: 534-538, 2014.